Back to Trades
Barrow Robert
Chief Executive OfficerDirectorCIK 0001897557
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 10
- Buy transactions
- 0
- Sell transactions
- 6
- Companies
- 1
- Active
- 2025–2026
Barrow Robert, Chief Executive Officer, Director, accounts for 10 disclosed filings worth $4.2M, all concentrated in Definium Therapeutics, Inc. (DFTX), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $4.2M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Sep 29 | DFTX Definium Therapeutics, Inc. | Barrow Robert | Chief Executive Officer, Director | Sell | $1.2M |
| Sep 14 | DFTX Definium Therapeutics, Inc. | Barrow Robert | Insider | Grant | $0 |
| Sep 4 | DFTX Definium Therapeutics, Inc. | Barrow Robert | Insider | Sell | $721.7K |
| Aug 12 | DFTX Definium Therapeutics, Inc. | Barrow Robert | Insider | Grant | $0 |
| Jun 26 | DFTX Definium Therapeutics, Inc. | Barrow Robert | Insider | Sell | $1.3M |
| Jun 22 | DFTX Definium Therapeutics, Inc. | Barrow Robert | Insider | Grant | $0 |
| Mar 26 | DFTX Definium Therapeutics, Inc. | Barrow Robert | Insider | Sell | $451.2K |
| Feb 5 | DFTX Definium Therapeutics, Inc. | Barrow Robert | Insider | Grant | $0 |
| Dec 29 | MNMD Mind Medicine (MindMed) Inc. | Barrow Robert | Insider | Sell | $339.1K |
| Sep 26 | MNMD Mind Medicine (MindMed) Inc. | Barrow Robert | Insider | Sell | $252.0K |
10 filings